CA2829792C - Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe - Google Patents

Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe Download PDF

Info

Publication number
CA2829792C
CA2829792C CA2829792A CA2829792A CA2829792C CA 2829792 C CA2829792 C CA 2829792C CA 2829792 A CA2829792 A CA 2829792A CA 2829792 A CA2829792 A CA 2829792A CA 2829792 C CA2829792 C CA 2829792C
Authority
CA
Canada
Prior art keywords
myrrh
vaginal
treatment
extract
vaginal atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2829792A
Other languages
English (en)
Other versions
CA2829792A1 (fr
Inventor
Eva Brandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sonia Pharma GmbH
Original Assignee
Sonia Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/050,225 external-priority patent/US8287924B2/en
Priority claimed from EP11158593.1A external-priority patent/EP2500026B1/fr
Application filed by Sonia Pharma GmbH filed Critical Sonia Pharma GmbH
Publication of CA2829792A1 publication Critical patent/CA2829792A1/fr
Application granted granted Critical
Publication of CA2829792C publication Critical patent/CA2829792C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

L'invention porte sur une nouvelle indication médicale de myrrhe, à savoir le traitement de l'atrophie vaginale en tant que symptôme ménopausique. L'invention porte en outre sur une préparation pharmaceutique sous forme de dosage vaginal pour le traitement de l'atrophie vaginale et sur un procédé de préparation d'une préparation pharmaceutique contre l'atrophie vaginale en tant que symptôme ménopausique.
CA2829792A 2011-03-17 2012-03-15 Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe Active CA2829792C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/050,225 US8287924B2 (en) 2011-03-17 2011-03-17 Treatment of menopausal symptoms as novel indication for myrrh
EP11158593.1A EP2500026B1 (fr) 2011-03-17 2011-03-17 Traitement des symptômes de la ménopause en tant que nouvelle indication pour myrrhe
EP11158593.1 2011-03-17
US13/050,225 2011-03-17
PCT/EP2012/054548 WO2012123539A1 (fr) 2011-03-17 2012-03-15 Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe

Publications (2)

Publication Number Publication Date
CA2829792A1 CA2829792A1 (fr) 2012-09-20
CA2829792C true CA2829792C (fr) 2017-04-04

Family

ID=45929506

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2829792A Active CA2829792C (fr) 2011-03-17 2012-03-15 Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe

Country Status (8)

Country Link
JP (1) JP5519879B2 (fr)
KR (1) KR20130130034A (fr)
AU (1) AU2012228213B2 (fr)
BR (1) BR112013023092A2 (fr)
CA (1) CA2829792C (fr)
CO (1) CO6771460A2 (fr)
MX (1) MX352788B (fr)
WO (1) WO2012123539A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2967506A1 (fr) 2016-01-18 2017-07-18 Nadiah Abdulkarim A. Alessa Composition de traitement et de prevention d'infection, ulcerations et furoncles attribuables au virus du papillome humain (vph)
WO2020006191A1 (fr) * 2018-06-29 2020-01-02 The Procter & Gamble Company Compositions pour soins vaginaux
WO2021123925A1 (fr) * 2019-12-15 2021-06-24 Banooye Armaghan Teb Compositions à base d'herbes et procédés d'administration servant au traitement d'infections et d'inflammation vulvovaginale et des organes pelviens

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592912A (en) 1983-10-31 1986-06-03 Harriet Nickolaus Ache and pain relieving and preventing composition
US4719111A (en) 1985-06-14 1988-01-12 Wilson Lynn M Novel composition for treatment of decubitus ulcers
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
AU630561B2 (en) 1990-06-12 1992-10-29 Cathy Palou A therapeutic preparation containing myrrh for treating skin disorders
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5248503A (en) 1992-01-03 1993-09-28 Emanuel King Rosalba Herbal dietary supplement
US6077513A (en) 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)
ZA200000192B (en) * 1998-10-30 2000-08-07 Jullienne Jacques Roger Jean M Novel composition.
US6893648B2 (en) 2002-01-04 2005-05-17 Harold Mermelstein Composition and method for treatment of vaginal dryness
CN1559586A (zh) * 2004-03-04 2005-01-05 健 曹 一种治疗妇科疾病的外用中成药
CN1679687A (zh) 2005-02-02 2005-10-12 姚素英 一种治疗妇科疾病外用胶囊及制备方法
CN101057892B (zh) * 2006-04-19 2010-11-10 河南省宛西制药股份有限公司 一种治疗***疾病的药物组合物及其制备方法和应用
CN101849981B (zh) * 2010-06-22 2011-11-23 南京中医药大学 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用

Also Published As

Publication number Publication date
JP5519879B2 (ja) 2014-06-11
WO2012123539A1 (fr) 2012-09-20
KR20130130034A (ko) 2013-11-29
AU2012228213A1 (en) 2013-09-12
MX352788B (es) 2017-12-05
CA2829792A1 (fr) 2012-09-20
JP2014508158A (ja) 2014-04-03
AU2012228213B2 (en) 2015-08-06
MX2013010415A (es) 2013-12-02
BR112013023092A2 (pt) 2016-12-06
CO6771460A2 (es) 2013-10-15

Similar Documents

Publication Publication Date Title
WO2019195943A1 (fr) Extrait de racine de cannabis, procédé de fabrication, procédé d'utilisation
JP2005501851A (ja) 毒素を除去するための組成物
Jain et al. A potential ethnomedicinal plant Semecarpus anacardium Linn. A review
US20190151232A1 (en) Topical Compositions, Process of Manufacture and Method of Use
US20240024374A1 (en) Topical composition comprised of cod li ver oil for treating wounds and skin disorders
JP4805589B2 (ja) エストロゲン様作用剤
JP2022079461A (ja) 女性更年期症状改善用組成物
CA2829792C (fr) Traitement de l'atrophie vaginale en tant qu'une nouvelle indication de myrrhe
MX2012001611A (es) Medicamento topico para el tratamiento de psoriasis.
US20100255131A1 (en) Stable hydrophobic topical herbal formulation
US8287924B2 (en) Treatment of menopausal symptoms as novel indication for myrrh
EP2500026B1 (fr) Traitement des symptômes de la ménopause en tant que nouvelle indication pour myrrhe
US20170333446A1 (en) Compounded formula for menopause relief
JP4837930B2 (ja) 抗エストロゲン作用剤
KR20110000250A (ko) 전립선을 위한 건강식품 및 이의 제조방법
Artz Vitex agnus-castus
JP2006143659A (ja) 皮膚外用剤
do Sameiro Barroso Medicine and magic in a recipe of Aspasia, a sixth-century CE Byzantine physician
WO2023072772A1 (fr) Produits pour traiter et/ou prévenir des symptômes menstruels
Kinai Medical Aromatherapy For Healthcare Professionals
JP2020511488A (ja) 前立腺の病変におけるＣｏｐａｉｆｅｒａ属オレオレジンの使用
RU2353348C1 (ru) Мазь для лечения аллергических заболеваний кожи широкого спектра действия
van Die Herbal medicine and menopause: an historical perspective
CAMPOS et al. AND FRANCISCO FERREIRA
Guba Vitex Berry Essential Oil.

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130909